Comparison results
Results: Differences General | ✘C96.2 | ✘C93.1 | ||||||||||
Related research | Analogs | Analogs | ||||||||||
| ||||||||||||
Distinctive symptoms | ||||||||||||
Register, to see more distinctive signs of diseases and studies | 48% | — | ||||||||||
Register, to see more distinctive signs of diseases and studies | — | 100% | ||||||||||
feeling of fullness | 26% | — | ||||||||||
chronic monocytic leukemia | — | 84% | ||||||||||
myelofibrosis | 22% | — | ||||||||||
mchc reduced | — | 70% | ||||||||||
myeloid metaplasia | 20% | — | ||||||||||
leukocyturia | — | 58% | ||||||||||
oncology | 19% | — | ||||||||||
alcoholism | — | 57% | ||||||||||
multiple organ failure | 16% | — | ||||||||||
monocytosis | — | 55% | ||||||||||
aggressive | 13% | — | ||||||||||
acute leukemia | — | 55% | ||||||||||
acute condition | 12% | — | ||||||||||
proteinuria | — | 53% | ||||||||||
control issues | 12% | — | ||||||||||
alcohol dependence | — | 53% | ||||||||||
skin condition | 12% | — | ||||||||||
professional cancer | — | 45% | ||||||||||
skin problems | 11% | — | ||||||||||
thrombocytopenia | — | 34% | ||||||||||
consequences of taking medications | 11% | — | ||||||||||
waldenstrom 's macroglobulinemia | — | 33% | ||||||||||
patient's condition | 11% | — | ||||||||||
erythrocytic anemia | — | 32% | ||||||||||
leukemia | 27% | 18% | ||||||||||
onset of illness | 11% | 42% | ||||||||||
cancer | 23% | 15% | ||||||||||
increased gamma globulins | — | 28% | ||||||||||
subacute condition | — | 24% | ||||||||||
hepatosplenomegaly | — | 22% | ||||||||||
enlargement of the spleen | — | 21% | ||||||||||
enlargement of the liver and spleen | — | 21% | ||||||||||
very correct | — | 21% | ||||||||||
chronic anemia | — | 21% | ||||||||||
increased ESR | — | 20% | ||||||||||
tuberculosis | — | 19% | ||||||||||
enlarged liver | — | 19% | ||||||||||
leukocytosis | — | 18% | ||||||||||
feeling of heat | — | 17% | ||||||||||
high temperature | — | 16% | ||||||||||
metastases | — | 16% | ||||||||||
anemia | — | 16% | ||||||||||
childhood diseases | — | 16% | ||||||||||
blood diseases | 15% | 31% | ||||||||||
chronic myeloid leukemia | 22% | 31% | ||||||||||
hemorrhagic syndrome | 17% | 25% | ||||||||||
chronic leukemia | 20% | 23% |
Instructions
Video
|